Sort by
Search results
CoaChrom® Prothrombin
Assay proposed for the measurement of prothrombin (Factor II) in research applications.
CoaChrom® Prothrombin -> SEE NEW REF. 400001
Assay proposed for the measurement of prothrombin (Factor II) in research applications.
CoaChrom™ Moderate Abnormal Control Plasma
Moderate Abnormal Control Plasma for the quality control of FVIII, FIX and vWF assays. For Research Use Only.
CoaChrom™ Severe Abnormal Control Plasma
Severe Abnormal Control Plasma for the quality control of FVIII, FIX and vWF assays. For Research Use Only.
Collagen
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome, storage pool disease) or acquired thrombopathy (e.g., myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
Corn Trypsin Inhibitor (CTI)
FXIIa inhibitor.
DOAC-Remove™20
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
DOAC-Remove™50
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
DOAC-Remove™250
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
DP-Filter®
DP-Filter ® is effective in filtering direct oral anticoagulants (DOACs), which interfere in various coagulometric coagulation tests, from citrated plasma providing anticoagulant-free plasma that can be used for testing. For research use only.